Table 7.
Glycan structure | Reference range from 40 controls | P8 ♀ | P9 ♀ | P12 ♀ | P10 ♀ | P11 ♀ | P13 ♀ | P14 ♀ |
---|---|---|---|---|---|---|---|---|
2 years | 5 years | 9.5 years | 6 years | 6 years | 9 years | 8.5 years | ||
AMH 3.55 μg/L | AMH 1.69 μg/L | AMH 3.085 μg/L | AMH 0.02 μg/L | AMH 0.02 μg/L | AMH 0.025 μg/L | AMH 0.015 μg/L | ||
Q188R/ N314D/ L218L/ D197G | T138M/ V157I | K285N/ D98N | Q188R/ Q188R | Q188R/ Q188R | Q188R/ Q188R | Q188R/ Q188R | ||
0.22 μM -1.14 μM | 0.51 | 0.56 | 2.9** | 0.5 | 0.86 | 3.45** | 1.77** | |
11.7 μM -31.4 μM | 18.8 | 15.5 | 36.3** | 15.3 | 21.7 | 34.9** | 28.4 | |
T/ST | ≤0.06 | 0.03 | 0.04 | 0.08** | 0.03 | 0.0 4 | 0.10** | 0.06 |
P10, P11, P13, and P14 all showed signs of ovarian dysfunction; P8, P9, and P12 did not. Core1Tn-antigen (T), sialyl-T antigen (ST), and the ratio of T/ST are presented. Glycan symbols: □: N-acetylgalactosamine (GalNAc); ○: galactose; ◆ : sialic acid (Neu5Ac). Shading and statistical significance are the same as for Table 1